Sponsor:
UCLA
Code:
NCT04804241
Conditions
Mild Cognitive Impairment
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Accepted
Interventions
Senicapoc
Placebo Tablet
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by University of California, Davis on 2025-07-17.